Adlard J.W., Richman S.D., Seymour M.T., Quirke P. Prediction of the response of colorectal cancer to systemic therapy // Lancet Oncol. - 2002. - Vol. 3. - P. 75-82.
Aschele C., Lonardi S., Monfardini S. Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer // Cancer Treat. Rev. - 2002. - Vol. 28. - P. 27-47.
Beutler E., Gelbart T., Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism // Proc. Natl Acad. Sci. USA. - 1998. - Vol. 95. - P. 8170-8174.
Braybrooke J.P., Levitt N.C., Joel S. et al. Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase II alpha expression // Clin. Cancer Res. - 2003. - Vol. 9. - P. 4682-4688.
Burton A. What went wrong with Iressa // Lancet Oncol. - 2002. - Vol. 3. - P. 708.
Cappuzzo F., Varella-Garcia M., Shigematsu H. et al. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients // J. Clin. Oncol. - 2005. - Vol. 23. - P. 5007-5018.
Chabner B.A., Roberts T.G. Timeline: Chemotherapy and the war on cancer // Nat. Rev. Cancer. - 2005. - Vol. 5. - P. 65-72.
Chan S.K., Gullick W.J., Hill M.E. Mutations of the epidermal growth factor receptor in non-small cell lung cancer - search and destroy // Eur. J Cancer. - 2006. - Vol. 42. - P. 17-23.
Chiusolo P., Reddiconto G., Casorelli I. et al. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate // Ann. Oncol. - 2002. - Vol. 13. - P. 1915-1918.